Tactics of radiographic diagnostics of breast cancer in women with inherited predisposition
https://doi.org/10.17650/1994-4098-2014-0-4-29-34
Abstract
With conventional approaches to mammography tissue examination in women over 40 years of age, mammography has been found to be less
effective for a group of younger women with negative family histories (cancer in the family) and BRCA1 and BRCA2 gene mutation carriers.
A distinct approach to mammography tissue examination in women with a hereditary disposition, involving additional examination methods
with due regard for age, is therefore suggested.
About the Authors
M. S. Karpova
N.N. Blokhin Russian Cancer Research Cancer, Moscow
Russian Federation
Russian Federation
G. P. Korzhenkova
N.N. Blokhin Russian Cancer Research Cancer, Moscow
Russian Federation
Russian Federation
L. N. Lyubchenko
N.N. Blokhin Russian Cancer Research Cancer, Moscow
Russian Federation
Russian Federation
References
1. Breast Cancer Linkage Consortium (BCLC). Familial Cancer 2003;2(3–4):18–32.
2. Antoniou A., Pharoah P.D., Narod S. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analisys of 22 studies. Am J Hum Genet 2003;72(5):1117–30.
3. Nathanson K.L., Wooster R., Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med 2001;7(5):552–6.
4. Brekelmans C.T., Seynaeve C., Bartels C.C. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19(4):924–30.
5. Scheuer L., Kauff N., Robson M. et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20(5): 1260–8.
6. Komenaka I.K., Ditkoff B.A., Joseph K.A. et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100(10):2079–83.
7. Goffin J., Chappuis P.O., Wong N., Foulkes W.D. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93(22):1754–5.
8. Houssami N., Cuzick J., Dixon J.M. The prevention, detection, and management of breast cancer. Med J Aust 2006;84(5): 230–4.
9. Stomper P.C., D’Souza D.J., DiNitto P.A., Arredondo M.A. Analysis of parenchymal density on mammograms in 1353 women 25–79 year old. Am J Roentgenol 1996;167(5):1261–5.
10. Lehman C.D., White E., Peacock S. et al. Effect of age and breast density on screening mammograms with false-positive findings. AJR Am J Roentgenol 1999;173(6):1651–5.
11. Kolb T.M., Lichy J., Newhouse J.H. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998;207(1): 191–9.
12. Zonderland H.M., Coerkamp E.G., Hermans J. еt аl. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999;213(2): 413–22.
13. Rosenberg R.D., Hunt W.C., Williamson M.R. et al. Effect of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209(2):511–8.
14. Davis P.L., McCarty K.S. Jr. Sensitivity of enhanced MRI for detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol 1997;7 Suppl 5:289–98.
15. Orel S.G., Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1):13–30.
16. Heywang-Kobrunner S.H., Viehweg P., Heinig A., Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24(2):94.108.
17. Kriege M., Brekelmans C.T., Boetes C. „ut al.; Magnetic Resonance Imaging Screening Study Group. Efficacy of breast cancer screening with MRI and mammography in women with a familial or genetic predisposition. N Eng J Med 2004;351(5): 427.37.
18. Wakeford R. The cancer epidemiology of radiation. Oncogene 2004;23(38): 6404.28.
19. Jansen-van der Weide M.C, Greuter M.J., Jansen L. et al. Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. Eur Radiol 2010;20(11):2547.56.
20. Broeks A., Braaf L.M., Huseinovic A. et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 2007;9(2):106.14.
21. Leach M.O., Boggis C.R., Dixon A.K. et al; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365(9473):1769.78.
22. Warner E., Plewes D.B., Hill K.A. et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317.25.
23. Kuhl C.K., Schrading S., Leutner C.C. et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23(33):8469.76.
24. Lehman C.D., Blume J.D., Weatherall P. et al.; International Breast MRI Consortium Working Group. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103(9):1898.905.
25. Sardanelli F., Podo F., D'Agnolo G. et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242(3):698.715.
Review
For citations:
Karpova M.S., Korzhenkova G.P., Lyubchenko L.N. Tactics of radiographic diagnostics of breast cancer in women with inherited predisposition. Tumors of female reproductive system. 2014;(4):29-34. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-4-29-34
Views:
1672
Email this article 